<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
  <channel>
    <title><![CDATA[PeRSSonalized Neurology  on Webicina.Com]]></title>
    <link>http://www.webicina.com/perssonalized/?cat=2</link>
    <description>Follow PeRSSonalized Neurology  on Webicina.Com</description>
    
      <item>
        <title><![CDATA[Phantosmia During Radiation Therapy: A Report of 2 Cases]]></title>
        <link>http://jcn.sagepub.com/cgi/content/abstract/28/6/788?rss=1</link>
        <description><![CDATA[
Phantosmia is an infrequently reported and poorly understood qualitative olfactory disorder characterized by the perception of a frequently unpleasant odor in the absence of an odorant stimulus. Peripheral phantosmia is hypothesized to involve abnor]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[MCT8 Deficiency: Extrapyramidal Symptoms and Delayed Myelination as Prominent Features]]></title>
        <link>http://jcn.sagepub.com/cgi/content/abstract/28/6/792?rss=1</link>
        <description><![CDATA[
Monocarboxylate transporter 8 (MCT8) deficiency is an X-linked disorder resulting from an impairment of the transcellular transportation of thyroid hormones. Within the central nervous system thyroid hormone transport is normally mediated by MCT8. P]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Moebius Syndrome and Hydrosyringomyelia: Description of a New Association]]></title>
        <link>http://jcn.sagepub.com/cgi/content/abstract/28/6/798?rss=1</link>
        <description><![CDATA[
The diagnosis of Moebius syndrome, a rare congenital disorder, is primarily based on congenital facial and abducent nerve palsy. Involvement of other cranial nerves is also common. Occasionally the V, X, XI, and XII cranial nerves are involved, resu]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Resistance (Weight Lifting) Training in an Adolescent With McArdle Disease]]></title>
        <link>http://jcn.sagepub.com/cgi/content/abstract/28/6/802?rss=1</link>
        <description><![CDATA[
Owing to the risk of severe rhabdomyolysis, clinicians advise McArdle disease patients to refrain from strenuous exercise, particularly weight lifting. A 15-year-old male McArdle disease patient performed a 6-week, supervised, light- to moderate-int]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Thinking Ethically About Medical Mistakes]]></title>
        <link>http://jcn.sagepub.com/cgi/content/abstract/28/6/806?rss=1</link>
        <description><![CDATA[
Medical mistakes, especially ones with significant adverse events, can erode the trust and bonds between and among parents, patients, and health care professionals. Prevention of medical mistakes should be the goal of every health care organization,]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Abstracts From the 38th Annual Southern Pediatric Neurology Society Meeting, March 9, 2013, New Orleans, Louisiana]]></title>
        <link>http://jcn.sagepub.com/cgi/reprint/28/6/809?rss=1</link>
        <description><![CDATA[]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Botulinum Toxin Induces Chemodenervation of Intrafusal and Extrafusal Fibers]]></title>
        <link>http://jcn.sagepub.com/cgi/reprint/28/6/816?rss=1</link>
        <description><![CDATA[]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Response: Botulinum Toxin Induces Chemodenervation of Intrafusal and Extrafusal Fibers]]></title>
        <link>http://jcn.sagepub.com/cgi/reprint/28/6/817?rss=1</link>
        <description><![CDATA[]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Book Review: Introduction to Epilepsy]]></title>
        <link>http://jcn.sagepub.com/cgi/reprint/28/6/818?rss=1</link>
        <description><![CDATA[]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Book Review: Principles and Practice of Child Neurology in Infancy]]></title>
        <link>http://jcn.sagepub.com/cgi/reprint/28/6/818-a?rss=1</link>
        <description><![CDATA[]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[JCN Calendar of Events]]></title>
        <link>http://jcn.sagepub.com/cgi/reprint/28/6/820?rss=1</link>
        <description><![CDATA[]]></description>
        <pubDate>Wed, 15 May 2013 18:18:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / NeurologySpecia]]></title>
        <link>http://twitter.com/NeurologySpecia</link>
        <description><![CDATA[Twitter updates from Dr Neil R. Holland / NeurologySpecia.]]></description>
        <pubDate>Wed, 15 May 2013 11:21:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Tue, 14 May 2013 18:50:09 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1850?rss=1</link>
        <description><![CDATA[
Objective:
The underlying pathophysiology of tremor in Parkinson disease (PD) is unclear; however, it is known that tremor does not appear to be as responsive to dopaminergic medication as bradykinesia or rigidity. It is suggested that serotonergic ]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The midbrain to pons ratio: A simple and specific MRI sign of progressive supranuclear palsy]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1856?rss=1</link>
        <description><![CDATA[
Objectives:
MRI-based measurements used to diagnose progressive supranuclear palsy (PSP) typically lack pathologic verification and are not easy to use routinely. We aimed to develop in histologically proven disease a simple measure of the midbrain ]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1862?rss=1</link>
        <description><![CDATA[
Objective:
The objective of this randomized, double-blind, placebo-controlled, crossover study was to examine if patients with optic neuropathy would derive a therapeutic benefit from 4-aminopyridine (4-AP) treatment. Furthermore, the study was inte]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Cerebellar learning distinguishes inflammatory neuropathy with and without tremor]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1867?rss=1</link>
        <description><![CDATA[
Objectives:
This study aims to investigate if patients with inflammatory neuropathies and tremor have evidence of dysfunction in the cerebellum and interactions in sensorimotor cortex compared to nontremulous patients and healthy controls.

Methods:]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Motor neuron involvement in multisystem proteinopathy: Implications for ALS]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1874?rss=1</link>
        <description><![CDATA[
Objective:
To explore the putative connection between inclusion body myopathy, Paget disease, frontotemporal dementia (IBMPFD) and motor neuron disease (MND).

Methods:
Clinical, genetic, and EMG characterization of 17 patients from 8 IBMPFD familie]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1881?rss=1</link>
        <description><![CDATA[
Objective:
We aimed to assess sensitivity and specificity of the updated criteria for behavioral variant frontotemporal dementia (bvFTD) based on a large autopsy-confirmed cohort of patients with dementia.

Methods:
Two hundred thirty-nine consecuti]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1888?rss=1</link>
        <description><![CDATA[
Objective:
To explore whether prevalence, survival, and incidence of dementia have changed from 1987&ndash;1994 to 2001&ndash;2008 in Stockholm, Sweden.

Methods:
This study is based on 2 cross-sectional surveys of people aged 75 years or over condu]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Sodium valproate use is associated with reduced parietal lobe thickness and brain volume]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1895?rss=1</link>
        <description><![CDATA[
Objective:
We hypothesized that total brain volume, white matter volume, and lobar cortical thickness would be different in epilepsy patients. We studied valproate relative to nonvalproate by using patients with epilepsy and healthy controls.

Metho]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Subcortical epilepsy?]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1901?rss=1</link>
        <description><![CDATA[
In the past, the cortex has for the most part been considered to be the site of seizure origin in the different forms of epilepsy. Findings from histopathologic, electrophysiologic, and brain imaging studies now provide ample evidence demonstrating ]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Recurrent myoglobinuria and deranged acylcarnitines due to a mutation in the mtDNA MT-CO2 gene]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1908?rss=1</link>
        <description><![CDATA[
Mitochondrial myopathies commonly present with exercise intolerance typified by breathlessness and fatigue on exercise. In contrast, exercise-induced rhabdomyolysis and myoglobinuria occur rarely. We present a 43-year-old man with a lifelong history]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Carotid dissection following a generalized tonic-clonic seizure]]></title>
        <link>http://www.neurology.org/cgi/content/short/80/20/1911?rss=1</link>
        <description><![CDATA[
A 37-year-old woman experienced a generalized tonic-clonic seizure. Subsequent to the seizure, the patient observed left-sided face and neck pain. A left Horner syndrome was noted on examination. An MRI and magnetic resonance angiogram revealed a le]]></description>
        <pubDate>Tue, 14 May 2013 05:06:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/44</link>
        <description><![CDATA[Background:
Carriers of the ApoE epsilon4 allele are at a greater risk for developing Alzheimer's disease (AD) and those who do develop AD tend to have a much greater neuropathological disease burden. Although several studies have shown significant d]]></description>
        <pubDate>Sat, 11 May 2013 19:27:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/44</link>
        <description><![CDATA[Background:
Carriers of the ApoE epsilon4 allele are at a greater risk for developing Alzheimer's disease (AD) and those who do develop AD tend to have a much greater neuropathological disease burden. Although several studies have shown significant d]]></description>
        <pubDate>Sat, 11 May 2013 14:09:03 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Paradoxical worsening of seizure activity with pregabalin in an adult with isodicentric 15 (IDIC-15) syndrome involving duplications of the GABRB3, GABRA5 and GABRG3 genes]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/43</link>
        <description><![CDATA[Background:
Isodicentric 15 syndrome (IDIC-15) is due to partial duplications of chromosome 15 that may includes the q11--13 region that includes genes encoding the alpha5 (GABRA5) and beta3 - gamma3 (GABRB3) receptor subunits. The disease causes int]]></description>
        <pubDate>Fri, 10 May 2013 15:51:01 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Paradoxical worsening of seizure activity with pregabalin in an adult with isodicentric 15 (IDIC-15) syndrome involving duplications of the GABRB3, GABRA5 and GABRG3 genes]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/43</link>
        <description><![CDATA[Background:
Isodicentric 15 syndrome (IDIC-15) is due to partial duplications of chromosome 15 that may includes the q11--13 region that includes genes encoding the alpha5 (GABRA5) and beta3 - gamma3 (GABRB3) receptor subunits. The disease causes int]]></description>
        <pubDate>Fri, 10 May 2013 13:30:03 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Is tinnitus accompanied by hemifacial spasm in normal-hearing patients also a type of hyperactive neurovascular compression syndrome? a magnetoencephalography study]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/42</link>
        <description><![CDATA[Background:
Traditionally, tinnitus accompanied by hemifacial spasm has been considered a type of hyperactive neurovascular compression syndrome that is similar to hemifacial spasm alone because of the anatomically close relationship between the faci]]></description>
        <pubDate>Wed, 08 May 2013 12:00:06 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Is tinnitus accompanied by hemifacial spasm in normal-hearing patients also a type of hyperactive neurovascular compression syndrome? a magnetoencephalography study]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/42</link>
        <description><![CDATA[Background:
Traditionally, tinnitus accompanied by hemifacial spasm has been considered a type of hyperactive neurovascular compression syndrome that is similar to hemifacial spasm alone because of the anatomically close relationship between the faci]]></description>
        <pubDate>Wed, 08 May 2013 08:36:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/U4ZlCBmW6Q4/nrneurol.2013.75</link>
        <description><![CDATA[Nat. Rev. Neurol.9, 72–73 (2013); doi:10.1038/nrneurol.2012.277In the version of this article initially published, the competing interests of F. Zipp were not included. The error has been corrected for the HTML and PDF versions of the article.]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Advances in understanding the molecular basis of frontotemporal dementia]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/lXdvw9DJJ3A/nrneurol.2013.76</link>
        <description><![CDATA[Nat. Rev. Neurol.8, 423–434 (2012); doi:10.1038/nrneurol.2012.117In the version of this article initially published, the alignment of data in Table 1 was incorrect. The error has been corrected for the HTML and PDF versions of the article.]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Dementia: A new algorithm for molecular diagnostics in FTLD]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/KhFpdlMuk8U/nrneurol.2013.72</link>
        <description><![CDATA[Genetic diagnosis of frontotemporal lobar degeneration has become challenging since the identification of a number of autosomal dominantly inherited causative mutations. As highlighted in a new paper, careful characterization of the clinical picture ]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Stroke: A step closer to statin therapy for stroke?]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/_fF4n-mM_5o/nrneurol.2013.58</link>
        <description><![CDATA[Accumulating evidence suggests that statin therapy could assist functional recovery following acute ischaemic stroke. A recent study indicates that early administration of statins after intravenous thrombolysis for stroke improves functional outcomes]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Parkinson disease: Neurostimulation in PD—benefit of early surgery revealed]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/Th6cWWdtXbs/nrneurol.2013.66</link>
        <description><![CDATA[Studies over the past two decades have shown that neurostimulation provides symptomatic benefit to patients with Parkinson disease (PD). However, surgical intervention is considered only for patients in late stages of disease. Now, results from the E]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[White matter disease: Early treatment of inflammatory demyelinating disease]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/-LUW7DmCQ80/nrneurol.2013.59</link>
        <description><![CDATA[Multiple sclerosis and neuromyelitis optica—two inflammatory demyelinating diseases with different pathogenesis and treatment regimens—have overlapping clinical manifestations, which can make diagnosis at initial presentation difficult. Now, a ne]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The role of neuroplasticity in dopaminergic therapy for Parkinson disease]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/f04mrFvjFS4/nrneurol.2013.57</link>
        <description><![CDATA[Dopamine replacement is a mainstay of therapeutic strategies for Parkinson disease (PD). The motor response to therapy involves an immediate improvement in motor function, known as the short-duration response (SDR), followed by a long-duration respon]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Spinal cord tumours: advances in genetics and their implications for treatment]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/bSH2eT3nVCQ/nrneurol.2013.48</link>
        <description><![CDATA[Tumours of the spinal cord, although rare, are associated with high morbidity. Surgical resection remains the primary treatment for patients with this disease, and offers the best chance for cure. Such surgical procedures, however, carry substantial ]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The utility of cerebrospinal fluid analysis in patients with multiple sclerosis]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/t1hRKXhgZiE/nrneurol.2013.41</link>
        <description><![CDATA[Diagnosis of multiple sclerosis (MS) requires the exclusion of other possible diagnoses. For this reason, the cerebrospinal fluid (CSF) should be routinely analysed in patients with a first clinical event suggestive of MS. CSF analysis is no longer m]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Progress in gene therapy for neurological disorders]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/JE8Hatc8orM/nrneurol.2013.56</link>
        <description><![CDATA[Diseases of the nervous system have devastating effects and are widely distributed among the population, being especially prevalent in the elderly. These diseases are often caused by inherited genetic mutations that result in abnormal nervous system ]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The role of palliative care in patients with neurological diseases]]></title>
        <link>http://feeds.nature.com/~r/nrneurol/rss/current/~3/Vibd2FJH-KM/nrneurol.2013.49</link>
        <description><![CDATA[Palliative care aims to improve the quality of life of patients and their families affected by life-threatening illness. This approach applies to a large and growing proportion of neurological disorders, most prominently stroke and dementia. Challeng]]></description>
        <pubDate>Tue, 07 May 2013 11:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Facial bradykinesia]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/681?rss=1</link>
        <description><![CDATA[
The aim of this paper is to summarise the main clinical and pathophysiological features of facial bradykinesia in Parkinson's disease (PD) and in atypical parkinsonism. Clinical observation suggests that reduced spontaneous and emotional facial expr]]></description>
        <pubDate>Tue, 07 May 2013 11:15:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Prevalence of cognitive impairment in Chinese: Epidemiology of Dementia in Singapore study]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/686?rss=1</link>
        <description><![CDATA[
Objective
To study the prevalence of and associated factors for cognitive impairment and dementia in community dwelling Chinese from Singapore.

Methods
This study includes Chinese subjects from the Epidemiology of Dementia in Singapore (EDIS) study]]></description>
        <pubDate>Tue, 07 May 2013 11:15:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Association between cerebral microbleeds and cognitive function: a systematic review]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/693?rss=1</link>
        <description><![CDATA[
Background
Cerebral microbleeds (MBs), defined as haemorrhagic microvascular lesions or microangiopathy in the brain, have traditionally been considered clinically silent. Recent studies, however, suggest that MBs are associated with a decline in co]]></description>
        <pubDate>Tue, 07 May 2013 11:15:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/698?rss=1</link>
        <description><![CDATA[
Objective
To assess the current use of glucocorticoids (GCs) in Duchenne muscular dystrophy in the UK, and compare the benefits and the adverse events of daily versus intermittent prednisolone regimens.

Design
A prospective longitudinal observation]]></description>
        <pubDate>Tue, 07 May 2013 11:15:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Unilateral isolated hypoglossal nerve palsy associated with internal carotid artery dissection]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/706?rss=1</link>
        <description><![CDATA[  A 54-year-old healthy man was admitted to our hospital with acute dysarthria and mild impairment in swallowing and tongue movements, which he had noticed 2&nbsp;days before. He was not taking any drugs, and his medical history was unremarkable exce]]></description>
        <pubDate>Tue, 07 May 2013 11:15:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Impact of symptoms in patients with functional neurological symptoms on activities of daily living and health related quality of life]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/707?rss=1</link>
        <description><![CDATA[ When designing a randomised clinical study in patients with functional neurological symptoms (FNS) our problem was what the best primary outcome measure is in this group of patients: activities of daily living (ADL) or quality of life (QoL)? In pati]]></description>
        <pubDate>Tue, 07 May 2013 11:15:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Does rest tremor exclude the diagnosis of adult-onset primary dystonia?]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/708?rss=1</link>
        <description><![CDATA[  The diagnosis of adult-onset primary dystonia (AOPD) is mainly clinical, but requires the exclusion of any secondary causes. AOPD is characterised by sustained involuntary muscle contraction resulting in one or more body parts moved away from their]]></description>
        <pubDate>Tue, 07 May 2013 11:15:07 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/650?rss=1</link>
        <description><![CDATA[
A growing number of progressive heredodegenerative conditions mimic the presentation of Huntington's disease (HD). Differentiating among these HD-like syndromes is necessary when a patient with a combination of movement disorders, cognitive decline,]]></description>
        <pubDate>Tue, 07 May 2013 11:15:06 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/657?rss=1</link>
        <description><![CDATA[
Huntington's disease (HD) is a fatal autosomal dominant neurodegenerative disease involving progressive motor, cognitive and behavioural decline, leading to death approximately 20&nbsp;years after motor onset. The disease is characterised pathologic]]></description>
        <pubDate>Tue, 07 May 2013 11:15:06 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/666?rss=1</link>
        <description><![CDATA[
The catechol-O-methyltranferase (COMT) is one of the main enzymes that metabolise dopamine in the brain. The Val158Met polymorphism in the COMT gene (rs4680) causes a trimodal distribution of high (Val/Val), intermediate (Val/Met) and low (Met/Met) ]]></description>
        <pubDate>Tue, 07 May 2013 11:15:06 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology]]></title>
        <link>http://jnnp.bmj.com/cgi/content/short/84/6/674?rss=1</link>
        <description><![CDATA[
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterised by motor dysfunction (parkinsonism) and several non-motor features. Dysautonomia is a significant non-motor feature as well as a neuropsychiatric symptom. Autonomic d]]></description>
        <pubDate>Tue, 07 May 2013 11:15:06 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case--control studies]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/41</link>
        <description><![CDATA[Background:
Although the precise etiology of multiple sclerosis is largely unknown, there is some speculation that a prior history of surgery may be associated with the subsequent risk for developing the disease. Therefore, we aimed to examine surger]]></description>
        <pubDate>Mon, 06 May 2013 23:03:03 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Neurology Update]]></title>
        <link>http://mmcneuro.wordpress.com</link>
        <description><![CDATA[A neurology education blog from Dr Holland and The Monmouth Neuroscience Institute]]></description>
        <pubDate>Mon, 06 May 2013 22:05:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case--control studies]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/41</link>
        <description><![CDATA[Background:
Although the precise etiology of multiple sclerosis is largely unknown, there is some speculation that a prior history of surgery may be associated with the subsequent risk for developing the disease. Therefore, we aimed to examine surger]]></description>
        <pubDate>Mon, 06 May 2013 16:09:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Rapid-developed primary malignant myoepithelioma in the cavernous sinus: a case report]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/40</link>
        <description><![CDATA[Background:
Malignant myoepithelioma is a relatively rare malignant tumor occurring most frequently in the salivary glands. A few isolated cases have been described in other locations, including soft tissue, bone, lung, bronchus, oral cavity, nasopha]]></description>
        <pubDate>Sun, 05 May 2013 01:21:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Rapid-developed primary malignant myoepithelioma in the cavernous sinus: a case report]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/40</link>
        <description><![CDATA[Background:
Malignant myoepithelioma is a relatively rare malignant tumor occurring most frequently in the salivary glands. A few isolated cases have been described in other locations, including soft tissue, bone, lung, bronchus, oral cavity, nasopha]]></description>
        <pubDate>Sat, 04 May 2013 22:48:03 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Autosomal dominant hereditary ataxia in Sri Lanka]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/39</link>
        <description><![CDATA[Background:
Spinocerebellar ataxias (SCA) are a group of hereditary neurodegenerative disorders. Prevalence of SCA subtypes differ worldwide. Autosomal dominant ataxias are the commonest types of inherited ataxias seen in Sri Lanka. The aim of the st]]></description>
        <pubDate>Wed, 01 May 2013 23:39:03 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Autosomal dominant hereditary ataxia in Sri Lanka]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/39</link>
        <description><![CDATA[Background:
Spinocerebellar ataxias (SCA) are a group of hereditary neurodegenerative disorders. Prevalence of SCA subtypes differ worldwide. Autosomal dominant ataxias are the commonest types of inherited ataxias seen in Sri Lanka. The aim of the st]]></description>
        <pubDate>Wed, 01 May 2013 20:54:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Reviewer acknowledgement 2012]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/25</link>
        <description><![CDATA[Contributing reviewersThe editors of BMC Neurology would like to thank all our reviewers who have contributed to the journal in Volume 12 (2012).]]></description>
        <pubDate>Tue, 30 Apr 2013 00:24:03 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Reviewer acknowledgement 2012]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/25</link>
        <description><![CDATA[Contributing reviewersThe editors of BMC Neurology would like to thank all our reviewers who have contributed to the journal in Volume 12 (2012).]]></description>
        <pubDate>Mon, 29 Apr 2013 18:03:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Analysis of EIF4G1 in ethnic Chinese]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/38</link>
        <description><![CDATA[Background:
Eukaryotic translation initiation factor 4-gamma 1 (EIF4G1) gene mutations have recently been reported in autosomal dominant, late-onset Parkinson's disease (LOPD). We carried out genetic analysis to determine the prevalence of EIF4G1 var]]></description>
        <pubDate>Fri, 26 Apr 2013 14:00:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Analysis of EIF4G1 in ethnic Chinese]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/38</link>
        <description><![CDATA[Background:
Eukaryotic translation initiation factor 4-gamma 1 (EIF4G1) gene mutations have recently been reported in autosomal dominant, late-onset Parkinson's disease (LOPD). We carried out genetic analysis to determine the prevalence of EIF4G1 var]]></description>
        <pubDate>Fri, 26 Apr 2013 12:48:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Expensive Drugs Could Bankrupt Medicare!]]></title>
        <link>http://mmcneuro.wordpress.com/2013/04/25/20-expensive-drugs-that-could-bankrupt-medicare/</link>
        <description><![CDATA[The United States spent about $98 billion on pharmaceuticals in 2006. This is despite 10% less drug use than other countries.  The problem is that our drugs, on the whole, cost about 50% more than other countries, 77% more for brand name medications]]></description>
        <pubDate>Fri, 26 Apr 2013 03:10:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/37</link>
        <description><![CDATA[Background:
The Patient Determined Disease Steps (PDDS) is a promising patient-reported outcome (PRO) of disability in multiple sclerosis (MS). To date, there is limited evidence regarding the validity of PDDS scores, despite its sound conceptual dev]]></description>
        <pubDate>Fri, 26 Apr 2013 01:33:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/37</link>
        <description><![CDATA[Background:
The Patient Determined Disease Steps (PDDS) is a promising patient-reported outcome (PRO) of disability in multiple sclerosis (MS). To date, there is limited evidence regarding the validity of PDDS scores, despite its sound conceptual dev]]></description>
        <pubDate>Fri, 26 Apr 2013 00:48:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Stroke Awareness Month Event at Monmouth Medical Center]]></title>
        <link>http://mmcneuro.wordpress.com/2013/04/22/stroke-awareness-week-event-at-monmouth-medical-center/</link>
        <description><![CDATA[Did you know that May is National Stroke Awareness Month? On May 11, 1989, President George Bush signed Presidential Proclamation 5975 designating May as National Stroke Awareness Month at the urging of National Stroke Association. Since then, the Na]]></description>
        <pubDate>Tue, 23 Apr 2013 02:15:12 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Shear rate specific blood viscosity and shear stress of carotid artery in patients with lacunar infarction]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/36</link>
        <description><![CDATA[Background:
This study describes a new method for determining site-specific vascular shear stress using dynamic measures of shear rate and blood viscosity (BV) in the carotid arteries, and examines characteristics of carotid arterial shear stress amo]]></description>
        <pubDate>Fri, 19 Apr 2013 01:45:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Shear rate specific blood viscosity and shear stress of carotid artery in patients with lacunar infarction]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/36</link>
        <description><![CDATA[Background:
This study describes a new method for determining site-specific vascular shear stress using dynamic measures of shear rate and blood viscosity (BV) in the carotid arteries, and examines characteristics of carotid arterial shear stress amo]]></description>
        <pubDate>Thu, 18 Apr 2013 17:51:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[A systematic review of biomarkers for disease progression in Parkinson's disease]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/35</link>
        <description><![CDATA[Background:
Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was]]></description>
        <pubDate>Sat, 13 Apr 2013 03:36:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[A systematic review of biomarkers for disease progression in Parkinson's disease]]></title>
        <link>http://www.biomedcentral.com/1471-2377/13/35</link>
        <description><![CDATA[Background:
Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was]]></description>
        <pubDate>Sat, 13 Apr 2013 00:15:02 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Twitter / paulderoos]]></title>
        <link>http://twitter.com/paulderoos</link>
        <description><![CDATA[Twitter updates from Paul de Roos, MD / paulderoos.]]></description>
        <pubDate>Wed, 27 Mar 2013 15:03:04 +0100</pubDate>
      </item>
  
  </channel>
</rss>
